ArticleSouth Asian journal of cancer2025

TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers - A Single Institution Retrospective Analysis.

Ritam Joarder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.